Skip to content

Live Events
Sign Up / Login

Live Events
Sign Up / Login

MEC Basic Full List View

By pinki@katapult.biz / February 16, 2025

MEC Basic

Speciality

Author / Speaker

Title

Type of Media

Events

Search Entries:

«
1
…
31
32
33
34
35
…
74
»

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Locally Advanced NSCLC Chemotherapy / Targeted Therapy / Immunotherapy

Ana Velazquez Manana, MD, MSc

Stage III NSCLC – Surgical/Combined Modality

Stage III NSCLC – Surgical/Combined Modality

Douglas Liou, MD

Locally Advanced NSCLC- Radiation Therapy

Locally Advanced NSCLC- Radiation Therapy

Lucas K. Vitzthum, MD, MAS

Radiation in Early-Stage NSCLC

Radiation in Early-Stage NSCLC

Megan Daly, MD

Adjuvant/Neo-adjuvant Systemic Therapy

Adjuvant/Neo-adjuvant Systemic Therapy

Heather Wakelee, MD

Surgery for Early-Stage NSCLC

Surgery for Early-Stage NSCLC

Lisa Brown, MD, MAS, FACS

Pulmonary – From Diagnostics to Therapeutics

Pulmonary – From Diagnostics to Therapeutics

Nicholas Stollenwerk, MD

Lung Cancer Screening / Tobacco Control

Lung Cancer Screening / Tobacco Control

Natalie Lui, MD, MAS

Pharmacologic Review of Cardiotoxic Chemotherapies

Pharmacologic Review of Cardiotoxic Chemotherapies

Mayret Gonzalez, PharmD, BCPS

Antiemesis: A comparison of Treatment Approach between NCCN and ASCO Guidelines

Antiemesis: A comparison of Treatment Approach between NCCN and ASCO Guidelines

Diana Van Ostran, PharmD, BCOP

Contemporary Pharmacotherapy Management of High-grade Gliomas

Contemporary Pharmacotherapy Management of High-grade Gliomas

Alyssa Strohbusch, PharmD, MS, CPh, BCOP

Pharmacotherapy Management in Chronic Lymphocytic Leukemia (CLL)

Pharmacotherapy Management in Chronic Lymphocytic Leukemia (CLL)

Tiba Al Sagheer, PharmD, BCOP, BCACP

Most Relevant News in Multiple Myeloma in 2022

Most Relevant News in Multiple Myeloma in 2022

Robert Z. Orlowski, MD, PhD

Update on T-cell Lymphomas

Update on T-cell Lymphomas

Yuliya Linhares, MD

Modern Challenges and New Options for B-cell NHL

Modern Challenges and New Options for B-cell NHL

Eduardo Sotomayor, MD

New Developments in CLL

New Developments in CLL

Eduardo Sotomayor, MD

Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC

Most Relevant Data on Immunotherapy in Neo-Adjuvant, Adjuvant, and Metastatic NSCLC

Luis E. Raez, MD, FACP, FCCP

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Novel Mechanisms of Resistance Identified for Tyrosine Kinakse Inhibitors against ALk and Ros1 Tumors in NSCLC

Stephen Liu, MD

Advances in Targeted Therapy in Lung Cancer

Advances in Targeted Therapy in Lung Cancer

Edgardo S. Santos, MD, FACP

New Developments in Therapeutics for Metastatic Breast Cancer

New Developments in Therapeutics for Metastatic Breast Cancer

Helen Chew, MD

Breast Cancer Update in Hormone Sensitive Breast Cancer

Breast Cancer Update in Hormone Sensitive Breast Cancer

Ricardo H. Alvarez, MD

Novel Frontiers in the Use of ctDNA in Oncology

Novel Frontiers in the Use of ctDNA in Oncology

Julia Rotow, MD

Advances in Head and Neck Cancers Including Thyroid malignancies

Advances in Head and Neck Cancers Including Thyroid malignancies

Lori Wirth, MD

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Gynecologic Malignancies: Targeted Therapy-IO-Chemo Combinations

Mark S, Shahin, MD, FACOG, FACS

Updates in Kidney and Bladder Cancers

Updates in Kidney and Bladder Cancers

Jaime Merchan, MD

Displaying 801 - 825 of 1,833

Post navigation

← Previous View

6619 South Dixie Highway #341
Miami, FL 33143

Phone: 305.663.1628
Email: info@meccinc.com

Userful Links

Live Events

Categories

About Us

Why Subscribe
About Us
Accreditation

© 2025 MEC Inc. All rights reserved | Digital Marketing by Katapult Marketing

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok